Invex Therapeutics aims to re-purpose a diabetic drug for brain disorders such as idiopathic intracranial hypertension, traumatic brain injury and acute stroke. As the product is already in production and use there is an easy route to entry.
Supply is being soaked and the price has been slowly appreciating due to...
Selling absorbed at support indicating a reversal for long entry.
Possible target price is 0.18
Moving trend line down trend intercept support
Waiting for price action to confirm reaction to break up
Still bearish but bullish momentum could break the down trend
Use you trading strategy to confirm the bias